Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. (Q64625984)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. |
clinical trial |
Statements
Study to Investigate Which Clinical Risk Factors Are Considered by Physicians When Conducting Overall Febrile Neutropenia Risk Assessments for Patients Receiving Chemotherapy With an Intermediate (10% - 20%) Febrile Neutropenia Risk. (English)
0 references
December 2012
0 references
December 2013
0 references
1,007
0 references
18 year
0 references